Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
STAT3 Transcription Factor | 3 | 2022 | 872 | 0.980 |
Why?
|
Glucuronidase | 1 | 2024 | 205 | 0.820 |
Why?
|
Gryllidae | 4 | 2024 | 20 | 0.740 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2024 | 701 | 0.670 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2023 | 637 | 0.650 |
Why?
|
Graphite | 3 | 2024 | 77 | 0.650 |
Why?
|
Pericytes | 1 | 2022 | 299 | 0.640 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 2024 | 1119 | 0.620 |
Why?
|
Acute Kidney Injury | 4 | 2022 | 1943 | 0.600 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2024 | 1494 | 0.580 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2022 | 426 | 0.570 |
Why?
|
Kidney | 8 | 2023 | 7072 | 0.540 |
Why?
|
Fibrosis | 7 | 2024 | 2073 | 0.520 |
Why?
|
Ear | 1 | 2015 | 172 | 0.480 |
Why?
|
Cicatrix, Hypertrophic | 1 | 2015 | 80 | 0.470 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2024 | 2306 | 0.440 |
Why?
|
Fibrinogen | 3 | 2014 | 894 | 0.420 |
Why?
|
Kidney Diseases | 5 | 2016 | 2100 | 0.420 |
Why?
|
Cyclin-Dependent Kinase 5 | 2 | 2010 | 110 | 0.410 |
Why?
|
Reperfusion Injury | 3 | 2013 | 1043 | 0.380 |
Why?
|
Receptors, Virus | 1 | 2013 | 651 | 0.340 |
Why?
|
Interleukins | 3 | 2022 | 789 | 0.340 |
Why?
|
Adipocytes | 1 | 2015 | 1196 | 0.310 |
Why?
|
Protein Phosphatase 2 | 1 | 2010 | 231 | 0.300 |
Why?
|
Atherosclerosis | 1 | 2024 | 3418 | 0.300 |
Why?
|
Amide Synthases | 1 | 2007 | 14 | 0.290 |
Why?
|
Cell Adhesion Molecules | 1 | 2013 | 1610 | 0.280 |
Why?
|
Apoptosis | 7 | 2024 | 9508 | 0.280 |
Why?
|
Electrochemistry | 1 | 2007 | 142 | 0.280 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2017 | 2946 | 0.270 |
Why?
|
Alcohol Dehydrogenase | 1 | 2007 | 113 | 0.270 |
Why?
|
Kidney Tubules, Proximal | 3 | 2024 | 386 | 0.270 |
Why?
|
Protein Kinases | 1 | 2013 | 1611 | 0.270 |
Why?
|
Autophagy | 2 | 2024 | 1349 | 0.250 |
Why?
|
Heterozygote | 1 | 2012 | 2796 | 0.250 |
Why?
|
Aristolochic Acids | 1 | 2024 | 13 | 0.240 |
Why?
|
Cell Transdifferentiation | 2 | 2024 | 186 | 0.230 |
Why?
|
MicroRNAs | 4 | 2023 | 3787 | 0.230 |
Why?
|
Nanodiamonds | 1 | 2023 | 2 | 0.230 |
Why?
|
Carboplatin | 4 | 2008 | 787 | 0.230 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2024 | 292 | 0.220 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 2 | 2022 | 820 | 0.210 |
Why?
|
Mice, Inbred C57BL | 11 | 2024 | 22341 | 0.210 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2024 | 473 | 0.210 |
Why?
|
Membrane Glycoproteins | 1 | 2013 | 3692 | 0.210 |
Why?
|
Asparagine | 1 | 2023 | 120 | 0.210 |
Why?
|
Stem Cells | 1 | 2015 | 3537 | 0.200 |
Why?
|
Bystander Effect | 2 | 2015 | 89 | 0.200 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2024 | 478 | 0.200 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2022 | 17 | 0.200 |
Why?
|
Nanoparticles | 2 | 2024 | 1966 | 0.200 |
Why?
|
Cell Cycle | 1 | 2010 | 2920 | 0.200 |
Why?
|
Mitomycin | 2 | 2015 | 261 | 0.200 |
Why?
|
Smad7 Protein | 2 | 2019 | 39 | 0.200 |
Why?
|
Animals | 29 | 2024 | 168800 | 0.180 |
Why?
|
Biosensing Techniques | 1 | 2007 | 640 | 0.180 |
Why?
|
Ethanol | 1 | 2007 | 1326 | 0.180 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2022 | 614 | 0.170 |
Why?
|
Mice | 18 | 2024 | 81839 | 0.170 |
Why?
|
Arthritis, Experimental | 1 | 2022 | 291 | 0.170 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2024 | 752 | 0.160 |
Why?
|
Polycystic Kidney Diseases | 1 | 2020 | 133 | 0.160 |
Why?
|
Mice, Knockout | 6 | 2022 | 14456 | 0.160 |
Why?
|
MAP Kinase Signaling System | 2 | 2024 | 1490 | 0.160 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 2020 | 166 | 0.160 |
Why?
|
Signal Transduction | 6 | 2024 | 23605 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2024 | 2455 | 0.150 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2022 | 1331 | 0.150 |
Why?
|
Aortic Diseases | 1 | 2024 | 741 | 0.150 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2018 | 190 | 0.140 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2024 | 2877 | 0.140 |
Why?
|
Cells, Cultured | 6 | 2024 | 18967 | 0.140 |
Why?
|
Transforming Growth Factor beta | 1 | 2024 | 1996 | 0.130 |
Why?
|
Drug Design | 2 | 2018 | 1040 | 0.130 |
Why?
|
Aorta | 1 | 2024 | 2040 | 0.130 |
Why?
|
Cell Proliferation | 7 | 2024 | 10433 | 0.130 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2023 | 1318 | 0.130 |
Why?
|
Mice, Inbred BALB C | 5 | 2021 | 6215 | 0.130 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2016 | 68 | 0.130 |
Why?
|
Rats, Wistar | 3 | 2018 | 1886 | 0.130 |
Why?
|
Autoimmunity | 2 | 2022 | 1354 | 0.120 |
Why?
|
Macrophages | 4 | 2019 | 5776 | 0.120 |
Why?
|
Lupus Nephritis | 1 | 2019 | 323 | 0.120 |
Why?
|
Cell Death | 2 | 2019 | 1676 | 0.120 |
Why?
|
Toxicity Tests | 1 | 2015 | 112 | 0.120 |
Why?
|
DNA Damage | 4 | 2022 | 2463 | 0.120 |
Why?
|
Cysts | 1 | 2020 | 684 | 0.120 |
Why?
|
Longevity | 1 | 2022 | 1085 | 0.120 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1623 | 0.120 |
Why?
|
Cell Survival | 4 | 2019 | 5747 | 0.120 |
Why?
|
Primary Graft Dysfunction | 1 | 2015 | 112 | 0.110 |
Why?
|
Diabetic Nephropathies | 1 | 2021 | 968 | 0.110 |
Why?
|
Hedgehog Proteins | 1 | 2018 | 771 | 0.110 |
Why?
|
Environmental Pollutants | 1 | 2023 | 1294 | 0.110 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2022 | 3796 | 0.110 |
Why?
|
Th17 Cells | 2 | 2022 | 787 | 0.110 |
Why?
|
RNA, Messenger | 4 | 2018 | 12775 | 0.110 |
Why?
|
Fatty Acids | 1 | 2021 | 1805 | 0.110 |
Why?
|
Heme Oxygenase-1 | 1 | 2015 | 364 | 0.100 |
Why?
|
RNA, Small Interfering | 4 | 2021 | 3424 | 0.100 |
Why?
|
Inflammation | 3 | 2022 | 10860 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2018 | 2327 | 0.100 |
Why?
|
Phosphorylation | 3 | 2013 | 8292 | 0.100 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6961 | 0.100 |
Why?
|
Protein Biosynthesis | 2 | 2016 | 2091 | 0.100 |
Why?
|
Fluorouracil | 2 | 2007 | 1648 | 0.090 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2015 | 2040 | 0.090 |
Why?
|
Coordination Complexes | 1 | 2011 | 72 | 0.090 |
Why?
|
Intestines | 1 | 2019 | 1904 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 2 | 2012 | 2469 | 0.090 |
Why?
|
Glucose Transporter Type 4 | 1 | 2010 | 241 | 0.090 |
Why?
|
Pharmaceutical Preparations | 1 | 1998 | 1084 | 0.090 |
Why?
|
Bayes Theorem | 1 | 1998 | 2353 | 0.090 |
Why?
|
Disease Models, Animal | 3 | 2024 | 18321 | 0.080 |
Why?
|
Cell Line | 3 | 2024 | 15546 | 0.080 |
Why?
|
Caveolin 1 | 1 | 2011 | 255 | 0.080 |
Why?
|
Monocytes | 1 | 2019 | 2591 | 0.080 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2011 | 427 | 0.080 |
Why?
|
Liver Neoplasms | 2 | 2018 | 4352 | 0.080 |
Why?
|
Protein Binding | 3 | 2022 | 9301 | 0.080 |
Why?
|
Copper | 1 | 2011 | 365 | 0.080 |
Why?
|
Antineoplastic Agents | 5 | 2018 | 13635 | 0.080 |
Why?
|
In Situ Hybridization | 1 | 2012 | 1885 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 3112 | 0.080 |
Why?
|
DNA Primers | 1 | 2012 | 2824 | 0.070 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2008 | 615 | 0.070 |
Why?
|
Sequence Analysis, RNA | 1 | 2015 | 2039 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2824 | 0.070 |
Why?
|
Blotting, Western | 2 | 2012 | 5020 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 1883 | 0.070 |
Why?
|
Humans | 30 | 2024 | 766117 | 0.070 |
Why?
|
Multiple Sclerosis | 1 | 2022 | 3212 | 0.070 |
Why?
|
Miniaturization | 1 | 2007 | 150 | 0.070 |
Why?
|
Receptor, Insulin | 1 | 2010 | 838 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2022 | 3743 | 0.070 |
Why?
|
Adjuvants, Pharmaceutic | 1 | 2006 | 48 | 0.070 |
Why?
|
Electric Conductivity | 1 | 2007 | 405 | 0.070 |
Why?
|
beta-Cyclodextrins | 1 | 2006 | 66 | 0.070 |
Why?
|
Plasmids | 1 | 2011 | 2267 | 0.060 |
Why?
|
Base Sequence | 2 | 2015 | 12405 | 0.060 |
Why?
|
Kidney Tubules | 2 | 2019 | 453 | 0.060 |
Why?
|
Papillomaviridae | 2 | 2011 | 1137 | 0.060 |
Why?
|
Equipment Failure Analysis | 1 | 2007 | 831 | 0.060 |
Why?
|
Rats | 3 | 2018 | 23717 | 0.060 |
Why?
|
Mice, Transgenic | 3 | 2023 | 9540 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 4399 | 0.050 |
Why?
|
Antitubercular Agents | 1 | 2012 | 1380 | 0.050 |
Why?
|
Larva | 1 | 2024 | 511 | 0.050 |
Why?
|
Databases, Factual | 1 | 1998 | 8062 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2013 | 3140 | 0.050 |
Why?
|
Tumor Microenvironment | 1 | 2015 | 3942 | 0.050 |
Why?
|
Coumarins | 1 | 2022 | 119 | 0.050 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2022 | 178 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5784 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2022 | 11642 | 0.050 |
Why?
|
Interleukin-17 | 2 | 2021 | 922 | 0.050 |
Why?
|
Cell Line, Tumor | 7 | 2018 | 17071 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2010 | 3733 | 0.050 |
Why?
|
Disease Progression | 3 | 2019 | 13616 | 0.050 |
Why?
|
Caco-2 Cells | 1 | 2022 | 367 | 0.050 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2022 | 183 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5336 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8724 | 0.050 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2021 | 32 | 0.050 |
Why?
|
Computational Biology | 1 | 2013 | 3565 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 6 | 1 | 2021 | 59 | 0.050 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2022 | 324 | 0.050 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2022 | 367 | 0.040 |
Why?
|
Male | 10 | 2024 | 363935 | 0.040 |
Why?
|
Palmitic Acid | 1 | 2021 | 147 | 0.040 |
Why?
|
Serum Albumin, Bovine | 1 | 2021 | 319 | 0.040 |
Why?
|
Molecular Conformation | 2 | 2012 | 539 | 0.040 |
Why?
|
Antigens, CD | 1 | 2010 | 4025 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 11906 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2015 | 4277 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 2022 | 697 | 0.040 |
Why?
|
RNA Interference | 2 | 2021 | 2828 | 0.040 |
Why?
|
Neoplasms | 3 | 2018 | 22344 | 0.040 |
Why?
|
TRPP Cation Channels | 1 | 2020 | 177 | 0.040 |
Why?
|
Molecular Dynamics Simulation | 1 | 2022 | 422 | 0.040 |
Why?
|
Pyridines | 1 | 2011 | 2889 | 0.040 |
Why?
|
Diethylnitrosamine | 1 | 2018 | 45 | 0.040 |
Why?
|
Single-Cell Analysis | 1 | 2010 | 2536 | 0.040 |
Why?
|
Equipment Design | 1 | 2007 | 3489 | 0.040 |
Why?
|
Oncogene Protein v-akt | 2 | 2011 | 130 | 0.040 |
Why?
|
Tuberculosis | 1 | 2012 | 2010 | 0.040 |
Why?
|
Plaque, Amyloid | 1 | 2023 | 770 | 0.040 |
Why?
|
Synovial Membrane | 1 | 2022 | 512 | 0.040 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2019 | 159 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2011 | 5126 | 0.040 |
Why?
|
Epithelial Cells | 2 | 2024 | 3684 | 0.040 |
Why?
|
Sulfones | 1 | 2021 | 447 | 0.040 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 115 | 0.040 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2018 | 186 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2023 | 3051 | 0.040 |
Why?
|
Th1 Cells | 1 | 2022 | 1041 | 0.030 |
Why?
|
Endocytosis | 1 | 2021 | 952 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2021 | 8612 | 0.030 |
Why?
|
Cilia | 1 | 2020 | 498 | 0.030 |
Why?
|
Leupeptins | 1 | 2015 | 112 | 0.030 |
Why?
|
Macromolecular Substances | 1 | 2018 | 1430 | 0.030 |
Why?
|
HeLa Cells | 2 | 2015 | 3073 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2007 | 3436 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2009 | 715 | 0.030 |
Why?
|
Carcinoma | 1 | 2006 | 2313 | 0.030 |
Why?
|
Benzamides | 1 | 2021 | 1376 | 0.030 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 2015 | 94 | 0.030 |
Why?
|
Kinetics | 1 | 2023 | 6273 | 0.030 |
Why?
|
Fas Ligand Protein | 1 | 2015 | 214 | 0.030 |
Why?
|
Papillomavirus Infections | 1 | 2007 | 1637 | 0.030 |
Why?
|
Ancrod | 1 | 2014 | 7 | 0.030 |
Why?
|
DNA | 2 | 2023 | 7193 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2023 | 3159 | 0.030 |
Why?
|
Green Fluorescent Proteins | 2 | 2010 | 2062 | 0.030 |
Why?
|
Chemokines | 1 | 2019 | 959 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 1 | 2015 | 610 | 0.030 |
Why?
|
Species Specificity | 1 | 2019 | 2406 | 0.030 |
Why?
|
Microglia | 1 | 2023 | 1371 | 0.030 |
Why?
|
Smad2 Protein | 1 | 2014 | 144 | 0.030 |
Why?
|
beta Catenin | 1 | 2018 | 1047 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2057 | 0.030 |
Why?
|
DNA Repair | 1 | 2022 | 2048 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2014 | 378 | 0.030 |
Why?
|
Models, Biological | 1 | 2009 | 9445 | 0.030 |
Why?
|
PPAR gamma | 1 | 2015 | 484 | 0.030 |
Why?
|
Colitis | 1 | 2021 | 1240 | 0.030 |
Why?
|
Melanoma | 1 | 2011 | 5695 | 0.030 |
Why?
|
Ureteral Obstruction | 1 | 2014 | 293 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2007 | 5791 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 2018 | 1416 | 0.020 |
Why?
|
Enzyme Activation | 2 | 2008 | 3584 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14645 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3501 | 0.020 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2011 | 205 | 0.020 |
Why?
|
Trigonella | 1 | 2010 | 3 | 0.020 |
Why?
|
Cytochalasin B | 1 | 2010 | 74 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2015 | 1837 | 0.020 |
Why?
|
Mitochondria | 1 | 2024 | 3672 | 0.020 |
Why?
|
DNA Cleavage | 1 | 2011 | 56 | 0.020 |
Why?
|
Insulin Antagonists | 1 | 2010 | 17 | 0.020 |
Why?
|
Oxygen | 1 | 2022 | 4247 | 0.020 |
Why?
|
Genistein | 1 | 2010 | 87 | 0.020 |
Why?
|
Mice, SCID | 1 | 2015 | 2626 | 0.020 |
Why?
|
Microscopy, Video | 1 | 2010 | 241 | 0.020 |
Why?
|
Doxorubicin | 1 | 2017 | 2226 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2008 | 21074 | 0.020 |
Why?
|
Receptors, Death Domain | 1 | 2009 | 31 | 0.020 |
Why?
|
Tumor Stem Cell Assay | 1 | 2009 | 116 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2007 | 1407 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2023 | 3892 | 0.020 |
Why?
|
Female | 10 | 2024 | 396233 | 0.020 |
Why?
|
Genetic Markers | 1 | 2015 | 2603 | 0.020 |
Why?
|
Edetic Acid | 1 | 2009 | 274 | 0.020 |
Why?
|
Adipokines | 1 | 2011 | 308 | 0.020 |
Why?
|
Androstadienes | 1 | 2010 | 347 | 0.020 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 2008 | 220 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2007 | 20137 | 0.020 |
Why?
|
Cricetulus | 1 | 2010 | 807 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2022 | 4910 | 0.020 |
Why?
|
Obesity | 1 | 2011 | 13085 | 0.020 |
Why?
|
CHO Cells | 1 | 2010 | 1373 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2011 | 555 | 0.020 |
Why?
|
Culture Media | 1 | 2009 | 889 | 0.020 |
Why?
|
Plant Extracts | 1 | 2010 | 496 | 0.020 |
Why?
|
Cricetinae | 1 | 2010 | 2413 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4263 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2011 | 1947 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2008 | 874 | 0.020 |
Why?
|
Binding Sites | 1 | 2015 | 6001 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10737 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2009 | 1336 | 0.020 |
Why?
|
Cell Count | 1 | 2009 | 1825 | 0.020 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2007 | 428 | 0.020 |
Why?
|
Protein Transport | 1 | 2010 | 1939 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2010 | 1967 | 0.010 |
Why?
|
Liver | 1 | 2020 | 7559 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2014 | 3227 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2627 | 0.010 |
Why?
|
Transfection | 1 | 2011 | 5739 | 0.010 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2007 | 646 | 0.010 |
Why?
|
Ligands | 1 | 2009 | 3274 | 0.010 |
Why?
|
Up-Regulation | 1 | 2011 | 4133 | 0.010 |
Why?
|
Gene Expression | 1 | 2015 | 7582 | 0.010 |
Why?
|
Time Factors | 1 | 2023 | 40108 | 0.010 |
Why?
|
Weight Gain | 1 | 2011 | 2356 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2006 | 1743 | 0.010 |
Why?
|
Middle Aged | 3 | 2024 | 223083 | 0.010 |
Why?
|
Cell Membrane | 1 | 2009 | 3635 | 0.010 |
Why?
|
Lipids | 1 | 2011 | 3316 | 0.010 |
Why?
|
Drug Combinations | 1 | 2006 | 2076 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4565 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2011 | 13400 | 0.010 |
Why?
|
Down-Regulation | 1 | 2006 | 2927 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 17597 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2010 | 3107 | 0.010 |
Why?
|
NF-kappa B | 1 | 2006 | 2495 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 24276 | 0.010 |
Why?
|
Insulin | 1 | 2010 | 6604 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 59515 | 0.010 |
Why?
|
Aged | 2 | 2018 | 171219 | 0.010 |
Why?
|
Adult | 1 | 2018 | 223139 | 0.000 |
Why?
|